JELLYFISH STING ANTIDOTE
Phebra starts clinical trials
THE Australian pharmaceutical company Phebra, based at Lane Cove, has announced its support for a new clinical trial to test the efficacy of Magnesium Sulphate as an antidote for Irukandji Syndrome (IS), the acute pain caused by certain jellyfish stings.
SEEKING BUSINESS FEEDBACK
Strategy to guide economic activity
NORTH Sydney Council has contracted consultants SGS to prepare an Economic Development Strategy that will guide economic activity in the coming years.
UPGRADE FOR ICONIC VENUES
Community responds to design options
A $72 million state-of-the art aquatic centre, featuring a new pool, parking for 125 cars, a grandstand for 750 people and a harbourside park, is among the six design options North Sydney Council is now considering as part of the redevelopment of the iconic North Sydney Olympic Pool.